REGN SignalReason for this trade
1: Market is taking pullback from trendline
2: market is near high supply area
0.02BRL
19.75 BBRL
65.52 BBRL
About REGENERON PHDRN
Sector
CEO
Leonard S. Schleifer
Headquarters
Tarrytown
Website
Employees (FY)
13.45 K
Founded
1988
ISIN
BRREGNBDR005
FIGI
BBG00P14K7Y9
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where REGN34 is featured.
